Evidence mapPaperPMID 20186491Full record

ReviewReviews in endocrine & metabolic disorders2010

Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Corey E Tabit, William B Chung, Naomi M Hamburg, Joseph A Vita

Open access · greenAbstract readReview
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 271 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed, 3 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 3 syntheses or guidelines pooled it, 561 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Endothelial Metabolic Reprogramming Links Diabetes to Atherosclerosis.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  16. Review
  17. Review
  18. Drug-coated balloons and diabetes: a review.Cardiovascular diabetology · 2025
    Review
  19. Review
  20. Article

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Corey E TabitEvans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA.
William B Chung
Naomi M Hamburg
Joseph A Vita
Boston University · USBoston Medical Center · US

Funding

Clinical Utility of Endothelial Function in PADR01HL075795 · BOSTON MEDICAL CENTER · 2003 to 2005
$3.0M
Redox regulation in Endothelial Progenitor CellsP01HL081587 · BOSTON UNIVERSITY MEDICAL CAMPUS · 2005 to 2005
$2.3M
NHLBI NIH HHS HL081587NHLBI NIH HHS HL083269NHLBI NIH HHS HL083801NHLBI NIH HHS HL75795NHLBI NIH HHS K12 HL083781NHLBI NIH HHS P01 HL081587NHLBI NIH HHS P50 HL083801NHLBI NIH HHS R01 HL075795NHLBI NIH HHS R01 HL083269
6 · The paper itself

Abstract

Cardiovascular disease is a major complication of diabetes mellitus, and improved strategies for prevention and treatment are needed. Endothelial dysfunction contributes to the pathogenesis and clinical expression of atherosclerosis in diabetes mellitus. This article reviews the evidence linking endothelial dysfunction to human diabetes mellitus and experimental studies that investigated the responsible mechanisms. We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus.

Indexed as

AnimalsAtherosclerosisCardiovascular DiseasesDiabetes MellitusEndothelium, VascularHumansInflammationInsulin ResistanceMitochondriaNitric OxideNitric Oxide Synthase Type IIIOxidative StressPhosphatidylinositol 3-KinasesProtein Kinase CProtein Kinase C betaSignal TransductionNitric OxideNitric Oxide Synthase Type IIINOS3 protein, humanPhosphatidylinositol 3-KinasesProtein Kinase CProtein Kinase C beta

Identifiers

PMID20186491
PMCPMC2882637
OpenAlexW2078047202

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.